Reimbursement news and insurance coverage updates.
UK's NICE Recommends Genetic Testing for Therapy Selection in Stroke Patients
Clopidogrel is less effective at preventing subsequent strokes in patients with certain variations in the CYP2C19 gene and testing could aid treatment selection.
Experts at ASGCT Ponder How Payment Models May Evolve With Market Entrance of Costly Gene Therapies
Regulators, economists, and drugmakers discussed how the healthcare system can manage under the growing pressure of gene therapies with multimillion-dollar price tags.
Guardant Health Secures New Commercial Payor Coverage for Liquid Biopsy Cancer Profiling Test
With new coverage from Anthem Blue Cross and Blue Shield, Aetna, and Humana, the firm's Guardant360/Guardant360 CDx assay is now covered by all major commercial health insurers.
In Brief This Week: ImmPact Bio, Singlera Genomics, CRISPR Therapeutics, Ratio Therapeutics
News items for the week of May 8, 2023.
Medicare Covering Epic Sciences ctDNA Breast Cancer Panel, MDxHealth's Select MDx Test
Medicare is covering the 56-gene ctDNA panel that forms one component of the DefineMBC multiomic liquid biopsy test.